French software developer BrainTale announced it has received the CE Mark for a new release of its software-as-a-service (SaaS) product brainQuant, which offers clinically validated white-matter quantification.
brainQuant provides quantitative measures of white-matter microstructure from brain diffusion MRI scans. The product's new features now include a simplified user interface, patient follow-up and management, and an evolved visualization scale that enables brain white-matter quantification in clinical routine in intensive care.
BrainTale also announced it is participating in the first World Coma Day on 22 March, a virtual event organized by the Neurocritical Care Society, a U.S.-based organization.
